BACKGROUND: Coronary heart disease has emerged as a leading cause of death in
China. Although there is strong evidence for the use of antiplatelet, blood pressure …

Background A limited number of studies have examined the age and sex differences, and
potentially changing trends, in cardiac medication and procedure use in patients …

Background—Acute coronary syndrome (ACS) patients in the highest risk categories are
least likely to receive evidence-based treatments (EBTs). We sought to determine why …

Use of evidence-based medicine (EBM) improves outcomes after acute coronary syndromes
(ACS), yet patients often discontinue prescribed therapies after discharge. Although such …

PURPOSE: To determine the rates of patient adherence to key evidence-based therapies at
6 months after hospital discharge for an acute coronary syndrome. METHODS: In this …

Background The prescription of recommended medical therapies is a key factor to improve
prognosis after acute coronary syndromes (ACS). However, reasons for cardiovascular …

BACKGROUND: There are limited data on the recent trend in the use of optimal evidence-
based medical therapies after acute coronary syndromes (ACSs). We sought to evaluate (1) …

Aims We sought to evaluate international patterns of use and factors influencing use of
evidence-based medications early after ACS. Methods and results Using a database of 15 …

Several medications have individually been shown to reduce mortality in patients with acute
coronary syndromes (ACS), but data on long-term outcomes related to the use of …

Purpose Little is known on the use of evidence‐based medications in patients with acute
myocardial infarction (AMI) across all ages. We undertook this study to describe the patterns …